Navigation Links
Breast Cancer Drug Might Treat Bipolar Disorder

Tamoxifen may ease condition's mania phase, but side effects could be a problem, experts say

MONDAY, March 3 (HealthDay News) -- A drug commonly used to treat breast cancer may one day help manage symptoms of mania, or the "high" phase experienced by people with bipolar disorder, researchers say.

Men and women who took tamoxifen for three weeks experienced a significant lessening of their mania compared to people taking a placebo, the study found.

Whether or not tamoxifen will become a mainstay of treatment for bipolar disorder remains to be seen, however.

"The bad news is [that] this is something we would have to figure out how side effects are going to be a factor in long-term use," said one expert, Dr. Jane Ripperger-Suhler, assistant professor of psychiatry and behavioral science at Texas A&M Health Science Center College of Medicine and a psychiatrist with Scott & White Mental Health Center. "The good news is that people are thinking outside the box in terms of what might be effective for a particular disorder."

"More trials need to be conducted," added Dr. Ma-Li Wong, professor of psychiatry and vice chair for translational research at the University of Miami Miller School of Medicine. "Tamoxifen is not a drug that is without side effects. One needs to be careful in terms of drawing conclusions. Bipolar is not a short-term disorder and in clinical trials for breast cancer, you're talking about treatment of five years. Also, the dose used in this study is a bit high in comparison to that used in breast cancer."

The findings, by researchers at Dokuz Eylül University Medical School in Izmir, Turkey, are published in the March issue of Archives of General Psychiatry.

Tamoxifen helps suppress breast cancer by interfering with the action of the female hormone estrogen in the body.

The drug also inhibits the activity of a family of enzymes known as protein kinase C (PKC). Activity of PKC may be altered during the mania state of bipolar disorder, experts say. Existing drugs for the condition, including lithium and valproate sodium, inhibit PKC-associated signaling in the brain.

Previous animal studies as well as pilot trials in humans have suggested that tamoxifen might be effective in treating bipolar-related mania.

For the new study, 66 men and women with bipolar disorder and currently in a manic state, or mixed states that included mania, were randomly assigned to take 40 to 80 milligrams of tamoxifen a day or a placebo for up to three weeks.

Participants were also given up to 5 milligrams a day of the sedative lorazepam as needed.

Fifty patients completed the study.

At the end of three weeks, participants taking tamoxifen had significantly lower scores on tests used to measure the severity of mania, with 48 percent of them citing a reduction of at least half in their mania scores.

Those in the placebo group had slightly increased mania scores, and only 5 percent experienced a reduction of at least half in their mania scores.

Twenty-eight percent of those in the tamoxifen group reached the cut-off scores for remission from mania, compared to none in the placebo group, the researchers said.

More information

The U.S. National Institute of Mental Health has more on bipolar disorder.

SOURCES: Jane Ripperger-Suhler, M.D., assistant professor, psychiatry and behavioral science, Texas A&M Health Science Center College of Medicine, and psychiatrist, Scott & White Mental Health Center, Temple; Ma-Li Wong, M.D., professor of psychiatry and vice chair for translational research, University of Miami Miller School of Medicine; March 2008, Archives of General Psychiatry

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study of targeted therapies for breast cancer -- model for global clinical trials
2. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
3. Atypical protein kinase C stabilizes SRC-3 levels in breast cancer cells
4. Breast cancer death rates among black women not decreasing across all states
5. Breast cancer subtypes linked to survival from secondary brain tumors
6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
7. Representative Greg Harris, Senator Jacqueline Collins, Senator Iris Martinez and Fellow State Legislators to Join Susan G. Komen for the Cure in Announcing Groundbreaking Legislation to Reduce Breast Cancer Disparities; Will Hold Press Conference Friday
8. Cost of Breast Cancer Can Include Paycheck
9. Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50%
10. Hormone therapy increases frequency of abnormal mammograms, breast biopsies
11. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Post Your Comments:
Related Image:
Breast Cancer Drug Might Treat Bipolar Disorder
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology: